Chlamydia trachomatis infections: Progress and problems

Journal of Infectious Diseases

Volumn 179, Issue SUPPL. 2, 1999, Pages

  Stamm, Walter E ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; DOXYCYCLINE; ERYTHROMYCIN; HEAT SHOCK PROTEIN 60; TETRACYCLINE;

CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONFERENCE PAPER; FEMALE; HUMAN; IMMUNOPATHOLOGY; INFECTION CONTROL; MALE; MASS SCREENING; PELVIC INFLAMMATORY DISEASE; PREVALENCE; PRIORITY JOURNAL; SEXUALLY TRANSMITTED DISEASE; URINALYSIS;

EID: 0033381544     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/513844     Document Type: Conference Paper

References (31)

1. 1. World Health Organization. Sexually transmitted diseases. Press release WHO/64, 25 August 1995.
2. 2. Institute of Medicine. The hidden epidemic: confronting sexually transmitted diseases. Washington, DC: National Academy Press, 1996.
3. 3. Stamm WE, Hicks CB, Martin DH, et al. Azithromycin for empirical treatment of the nongonococcal urethritis syndrome in men. A randomized double-blind study. JAMA 1995;247:577-9.
4. 4. Stamm WE, Holmes KK. Chlamydia trachomatis infections of the adult. In: Holmes KK, Mârdh PA, Sparling PF, et al., eds. Sexually transmitted diseases. 2nd ed. New York: McGraw-Hill, 1990:181-93.
5. 5. Brunham RC, Peeling RW. Chlamydia trachomatis antigens: role in immunity and pathogenesis. Infect Agents Dis 1994;3:218-33.
6. 6. Peeling RW, Brunham RC. Chlamydiae as pathogens: new species and new issues. Emerg Infect Dis 1996;2:307-19.
7. 7. Lampe MF, Wong KG, Kuehl LM, Stamm WE. Chlamydia trachomatis major outer membrane protein variants escape neutralization by both monoclonal antibodies and human immune sera. Infect Immun 1997; 65:317-9.
8. 8. Morrison RP, Belland RJ, Lyng K, et al. Chlamydial disease pathogenesis: the 57 kD chlamydial hypersensitivity antigen is a stress response protein. J Exp Med 1989;170:1271.
9. 9. Eckert LO, Hawes SE, Wölner-Hanssen P, et al. Prevalence and correlates of antibody to chlamydial heat shock protein in women attending sexually transmitted disease clinics and women with confirmed pelvic inflammatory disease. J Infect Dis 1997;175:1453-8.
10. 10. Peeling RW, Kimani J, Plummer F, MacLean I, Cheang M, Brunham RC. Antibody to chlamydial hsp60 predicts an increased risk for chlamydial pelvic inflammatory disease. J Infect Dis 1997;175:1153-8.
11. 11. Money DM, Hawes SE, Eschenbach DA, et al. Antibodies to the chlamydial 60 kd heat-shock protein are associated with laparoscopically confirmed perihepatitis. Am J Obstet Gynecol 1997;176:870-7.
12. 12. Conway DJ, Holland MJ, Campbell AE, et al. HLA class I and II polymorphisms and trachomatous scarring in a Chlamydia trachomatis-endemic population. J Infect Dis 1996;174:643-6.
13. 13. Kimani J, MacLean IW, Bwayo J, et al. Risk factors for Chlamydia trachomatis pelvic inflammatory disease among sex workers in Nairobi, Kenya. J Infect Dis 1996;173:1437-44.
14. 14. Lichtenwalner AB, Patton DL, Sweeney CYT, Gaur LK, Stamm WE. Evidence of genetic susceptibility to Chlamydia trachomatis-induced pelvic inflammatory disease in the pig-tailed macaque. Infect Immun 1997;65:2250-3.
15. 15. Dean D, Schachter J, Dawson CR, Stephens RS. Comparison of the major outer membrane protein variant sequence regions of B/Ba isolates: a molecular epidemiologic approach to Chlamydia trachomatis infections. J Infect Dis 1992;166:383-92.
16. 16. Patton DL, Askienazy-Elbhar M, Henry-Suchet JH, et al. Detection of Chlamydia trachomatis in fallopian tube tissue in women with postinfectious tubal infertility. Am J Obstet Gynecol 1994;171:95-101.
17. 17. Cleary RE, Jones RB. Recovery of Chlamydia trachomatis from the endometrium in infertile women with serum antichlamydial antibodies. Fertil Steril 1985;44:233-5.
18. 18. Patton DL, Sweeney YC, Bohannon NJ, et al. Effects of doxycycline and antiinflammatory agents on experimentally induced chlamydial upper genital tract infection in female macaques. J Infect Dis 1997;175: 648-54.
19. 19. Schachter J, Stamm WE. Chlamydia. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Tolken RH, eds. Manual of medical microbiology. 6th ed. Washington, DC: American Society for Microbiology, 1995: 669-77.
20. 20. Black CM. Current methods of laboratory diagnosis of Chlamydia trachomatis infection. Clin Microbiol Rev 1997;10:160-84.
21. 21. Stamm WE. Azithromycin in the treatment of uncomplicated genital chlamydial infections. Am J Med 1991;3A:19-22S.
22. 22. Martin DH, Mroczkowski TF, Dalu ZA, et al. A controlled trial of a single dose of azithromycin for the treatment of chlamydial urethritis and cervicitis. N Engl J Med 1992;327:921-5.
23. 23. Lister PJ, Balechandran T, Ridgway GL, Robinson JA. Comparison of azithromycin and doxycycline in the treatment of non-gonococcal urethritis in men. J Antimicrob Chemother 1993;31:185-92.
24. 24. Magid D, Douglas JM, Schwanz JS. Doxycycline compared with azithromycin for treating women with genital Chlamydia trachomatis infections: an incremental cost-effectiveness analysis. Ann Intern Med 1996; 124:389-99.
25. 25. Handsfield HH, Stamm WE. Treating chlamydial infection: compliance versus cost. Sex Transm Dis 1998;25:12-3.
26. 26. Stergachis A, Scholes D, Heidrich FE, Sherer DM, Holmes KK, Stamm WE. Selective screening for Chlamydia trachomatis infections in a primary care population of women. Am J Epidemiol 1993;138: 143-53.
27. 27. Weinstock HS, Bolan GA, Kohn R, Balladares C, Back A, Oliva G. Chlamydia trachomatis infection in women: a need for universal screening in high prevalence populations? Am J Epidemiol 1992;132:41-7.
28. 28. Marrazzo JM, Celum CL, Hillis SD, Fine D, DeLisle S, Handsfield HH. Performance and cost-effectiveness of selective screening for chlamydial infection in women: implications for a national screening strategy. Sex Transm Dis 1997;24:131-41.
29. 29. Addiss DG, Vaughn ML, Ludka D, Pfister J, Davis JP. Decreased prevalence of Chlamydia trachomatis infection associated with a selective screening program in family planning clinics in Wisconsin. Sex Transm Dis 1993;20:28-35.
30. 30. Scholes D, Stergachis A, Heidrich FE, Andrilla H, Holmes KK, Stamm WE. Prevention of pelvic inflammatory disease by screening for cervical chlamydia infection. N Engl J Med 1996;334:1362-6.
31. 31. Marrazzo JM, White CL, Krekeler B, et al. Community-based urine screening for Chlamydia trachomatis with a ligase chain reaction assay. Ann Intern Med 1997;127:796-803.